skip to Main Content
Pharma_Licensing

Licensing in the UAE

The Federal Law of the UAE No. 17 of 2002, in the Regulation and protection of industrial property for patents and industrial designs in Article 1 clearly depicts the intent of the invention for which the patent is granted and…

Compulsory Licensing Under The Patents Act

Under the pre-2004 provisions of the Patents Act, section 55 of the Patents Act provided that an application may be made to court for the grant of a license after 3 years from the date of the grant of a…

Cipla’s plea for revocation of Novartis Patents for Onbrez may face major set back by the Government

As reported in TOI, the Indian Government has found very little merit in Cipla’s plea for waiver and cancellation of Patent rights for chronic obstructive pulmonary disease (COPD) drug over which Novartis has exclusive rights. We have reported on Cipla’s…

Cipla Files Representation with Govt. Seeking Revocation of Novartis’ Patents

It has been recently reported in Economic times that Cipla has filed representation with the government (Department of Industrial Policy & Promotion) seeking revocation of five patents of Novartis on indacaterol, a respiratory drug for the treatment of chronic obstructive…

Back To Top